More on DNTH

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Dianthus Therapeutics (NQ:DNTH)
Delayed: 80.32 +1.44 (1.83%)
Prev. Close $78.88  
Open$78.99 
52 Wk High$ 
52 Wk Low$ 
Day High$80.56 
Day Low$78.68 
P/E N/A  
EPS$ 
Volume37,319 

Friends, Peers and Foes (?): TOI, ALNY, ARGX, BBIO, BIIB (more...)

Jun 12, 2026 02:53 PM Raymond James on Dianthus Therapeutics (DNTH) Amid 8% Gain: 'Incrementally More Bullish On The CIDP Program (again)'
Jun 12, 2026 07:01 AM Form 8-K Dianthus Therapeutics, For: Jun 12
Jun 10, 2026 04:10 PM Guggenheim Defending Dianthus Therapeutics (DNTH): 'We reiterate our positive view'
Jun 10, 2026 03:52 PM Dianthus Therapeutics (DNTH) PT Raised to $132 at Jefferies
Jun 10, 2026 01:37 PM TD Cowen Defending Dianthus Therapeutics (DNTH): 'We see weakness as a buying opportunity'
Jun 10, 2026 01:01 PM Raymond James on Dianthus Therapeutics (DNTH) Amid 15% Down Day: 'We See Overall Positive Readthrough to Claseprubart'
Jun 10, 2026 10:40 AM Wolfe Research on Dianthus Therapeutics (DNTH): 'Not a negative but also not a strong positive'
Jun 10, 2026 10:38 AM Truist on Dianthus Therapeutics (DNTH) Amid Extreme Selloff: 'we believe the readthrough to DNTH should be limited'
Jun 10, 2026 07:21 AM Dianthus Therapeutics (DNTH) Reiterated at Buy by Stifel
Jun 2, 2026 07:00 PM Form 4 Dianthus Therapeutics, For: Jun 01 Filed by: Randhawa Simrat
View All Articles

Entities mentioned with dnth

View All Entities